Paradoxical action of zolpidem: interplay between dysregulation of the synergetic actions of γ-aminobutyric acid type A receptors and neuronal cotransporters (KCC2/NKCC1).
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic hypotheses without new empirical data
PubMed 40686063 · doi:10.1080/10799893.2025.2530105
What was done
This narrative review synthesized literature on the paradoxical awakening and neuro-restorative effects of zolpidem in individuals with brain injury (including trauma, stroke, disorders of consciousness, and hypoxic injury) and other neurological disorders. The authors focused on the interplay between zolpidem's target (GABA_A receptors) and neuronal cation-chloride cotransporters (KCC2 and NKCC1).
What was found
The abstract reports no quantitative data, statistical metrics, or patient counts. It presents a theoretical mechanism proposing that alterations in KCC2/NKCC1 cotransporter expression shift GABAergic transmission dynamics after brain injury, thereby enabling the sedative agent zolpidem to induce paradoxically activating effects.
Why it matters
Understanding the cellular mechanisms behind zolpidem-mediated paradoxical arousal could help clarify post-injury neuronal dysfunction and guide targeted therapeutic strategies for disorders of consciousness.
Limits
The paper is a narrative review presenting mechanistic reasoning rather than new empirical clinical trial data. No systematic search strategy, meta-analytic methods, or quantitative findings are described in the abstract.
Cited by
- supports Sedative-hypnotic sleep aids such as Ambien exert their sedative effects by acting on GABA receptors.